Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Clin Cancer Res. 2021 Mar 26;27(11):3050–3060. doi: 10.1158/1078-0432.CCR-20-4118

Table 1.

Baseline patient characteristics

Characteristics N (%) N = 21
Median Age (range) 66 years (47–78)

Gender
 Female 4 (19.0)
 Male 17 (81.0)

ECOG* performance status
 0 4 (19.0)
 1 17 (81.0)

Diagnosis
 castration-resistant prostate cancer 11 (52.4)
 Pancreatic cancer 7 (33.3)
 Melanoma 2 (9.5)
 HPV- head and neck squamous cell carcinoma 1 (4.8)

Median number of prior systemic therapies (range) 4 (1–9)

Prior immune checkpoint inhibitor 4 (19.0)
 HPV- head and neck squamous cell carcinoma 1 (4.8)
 Melanoma 2 (9.5)
 Castration-resistant prostate cancer 1 (4.8)

Median number of evofosfamide doses (range) 4 (2–8)

Median number of ipilimumab doses (range) 4 (1–8)
*

ECOG Eastern Cooperative Oncology Group